🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate the effects of nicotinic alpha-7 M...
Status
Unknown
Location
University of Colorado Health Sciences Center
Start Date
2008-08
Trial ID
NCT00725855
Treatments Being Tested
The purpose of this study is to evaluate the effect of subcutaneous adminis...
Status
Completed
Location
Aarhus University Hospital, Department of Neyrology
Start Date
2005-08
Trial ID
NCT00268788
Treatments Being Tested
The aim of this study is to evaluate the efficacy and safety of I10E (LFB 1...
Status
Completed
Location
CHU de Bordeaux -Hôpital Haut-Lévêque
Start Date
2013-12
Trial ID
NCT01951924
Sepsis-associated encephalopathy (SAE), is one of the most common organ dys...
Status
Unknown
Location
Nanjing Drum Tower Hospital
Start Date
2021-02-01
Trial ID
NCT04870983
The study will aim to compare the effects of a beverage powder fortified wi...
Status
Completed
Location
GSK Investigational Site
Start Date
2014-10
Trial ID
NCT02345187
Low birth weight (LBW; birth weight\<2,500g) is the most important determin...
Status
Completed
Location
Centre Muraz, 2054, Avenue Mamadou KONATE
Start Date
2006-02
Trial ID
NCT00909974
Treatments Being Tested
This prospective longitudinal study will follow participants with Multifoca...
Status
Active Not Recruiting
Location
Neuromuscular Clinical and Research Center
Start Date
2023-11-29
Trial ID
NCT05988073
The use of lipid-based nutrients (LNS), such as Nutributter or fortified sp...
Status
Active Not Recruiting
Location
University of Malawi, College of Medicine
Start Date
2011-02
Trial ID
NCT01239693
Intrauterine Growth Retardation is the most important determinant of mortal...
Status
Completed
Location
Centre Muraz, 2054, Avenue Mamadou KONATE
Start Date
2003-06
Trial ID
NCT00642408
Treatments Being Tested
This is a phase 2, randomized, double-blinded, placebo-controlled, parallel...
Status
Completed
Location
HonorHealth Research Institute-Neuroscience Research
Start Date
2022-03-31
Trial ID
NCT05225675